Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

Description

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

Conditions

Migraine

Talk to us

Study Overview

On this page

Study Details

Study overview

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

Does Nerve Block Plus Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hours Better Than Nerve Block Alone?

Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

Condition
Migraine
Intervention / Treatment

-

Contacts and Locations

El Paso

University Medical Center of El Paso, El Paso, Texas, United States, 79905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Meet ICHD-3 Migraine Headache Criteria
  • * Had a minimum 5-point reduction in headache intensity after nerve block(s) or post- block pain score of 0 to 2
  • * Nerve block performed with bupivacaine 0.5%
  • * Head trauma
  • * Suspicion of secondary headache (i.e. stroke, known tumor, glaucoma)
  • * Headache in the setting of viral syndrome
  • * Chronically on steroids
  • * Known allergy to dexamethasone
  • * Unable to reach the patient by phone or text for follow-up
  • * Gestational diabetes or other uncontrolled diabetes
  • * Known to be immunocompromised

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Texas Tech University Health Sciences Center, El Paso,

Susan Watts, PhD., STUDY_DIRECTOR, Texas Tech University Health Sciences Center, Department of Emergency Medicine

Study Record Dates

2024-09-10